Summary of Key Points Core Viewpoint - 瑞迈特 has announced adjustments to its fundraising project investment structure, including re-evaluations and delays for certain projects, which reflects a strategic shift in resource allocation to enhance marketing and R&D efforts [1]. Group 1: Stock Performance - As of February 3, 2026, 瑞迈特's stock closed at 82.71 yuan, up 1.86% from the previous trading day, with a total market capitalization of 7.411 billion yuan [1]. - The stock opened at 81.98 yuan, reached a high of 82.71 yuan, and a low of 80.87 yuan, with a trading volume of 61.1885 million yuan and a turnover rate of 1.07% [1]. Group 2: Project Adjustments - The company held a board meeting on February 3, 2026, where it approved adjustments to the internal investment structure of certain fundraising projects and the postponement of some project timelines [1]. - For the "Marketing Network and Brand Building Project," the company reduced investments in channel construction and overseas branches while increasing marketing promotion expenditures [1]. - The "Medical Equipment R&D Center Project" saw an increase in R&D investment but a decrease in renovation and equipment expenditures [1]. - The expected completion dates for the "Annual Production of 300,000 Ventilators and 3.5 Million Sets of Accessories" and the "Marketing Network and Brand Building Project" have been postponed to December 31, 2027, while the "Medical Equipment R&D Center Project" is now expected to be completed by December 31, 2026 [1].

Core Viewpoint - The major shareholders of Ruimai Te (301367.SZ) have announced plans to reduce their holdings, which may impact the stock's performance in the market [1][2]. Shareholder Reduction Plans - Nengjin Company and its concerted action partner, Guangzhou Jinyuan, plan to reduce their holdings by up to 888,325 shares, representing 1% of the total share capital, within three months after the announcement [1]. - Hehan Investment and its concerted action partners, Shengmin Chuangtou and Nanjing Hehao, plan to reduce their holdings by up to 2,666,169 shares, representing 3% of the total share capital, within the same timeframe [2]. Shareholding Structure - Nengjin Company holds 4,480,795 shares (5.00% of total shares) and Guangzhou Jinyuan holds 753.325 shares (0.84% of total shares) [3]. - Hehan Investment holds 11,155,686 shares (12.45% of total shares), while Shengmin Chuangtou holds 5,373,515 shares (6.00% of total shares) and Nanjing Hehao holds 358.589 shares (0.40% of total shares) [3]. Reduction Methods and Quantities - Nengjin Company plans to reduce up to 135,000 shares through centralized bidding, while Guangzhou Jinyuan plans to reduce up to 753.325 shares [5]. - Hehan Investment plans to reduce up to 530.134 shares through centralized bidding, and Shengmin Chuangtou plans to reduce up to 1,777,446 shares through block trading [5]. Market Context - Ruimai Te is currently in a state of share price decline, indicating a potential market challenge for the company [9].

Group 1 - The stock price of Ruimaite (301367.SZ) closed at 79.36 yuan, with a decline of 2.17%, currently below the issue price [1] - Yihe Jiaye was listed on the Shenzhen Stock Exchange's ChiNext on November 1, 2022, with a public offering of 16 million shares, accounting for 25% of the total share capital after issuance, at an issue price of 119.88 yuan per share [1] - The total amount raised by Yihe Jiaye was 191.808 million yuan, with a net amount of 173.82674 million yuan, exceeding the originally planned fundraising by 100.02698 million yuan [1] - The original fundraising plan was 73.79976 million yuan, intended for projects including the production of 300,000 ventilators and 3.5 million sets of accessories, marketing network and brand building, medical equipment R&D center, and working capital [1] - The underwriting institution for Yihe Jiaye was China International Capital Corporation (CICC), with representatives Chen Tingting and Xie Xianming [1] - The total issuance expenses amounted to 18.30202 million yuan, including underwriting and sponsorship fees of 15.71582 million yuan [1] - On May 22, 2024, Yihe Jiaye announced a dividend plan of 10 yuan (pre-tax) per 10 shares, with a bonus issue of 4 shares, with the ex-dividend date set for May 29, 2024 [1] Group 2 - On May 21, 2025, Yihe Jiaye announced a change of company name and stock abbreviation, changing from "Beijing Yihe Jiaye Medical Technology Co., Ltd." to "Beijing Ruimaite Medical Technology Co., Ltd." while the stock code "301367" remains unchanged [2]